PND5 Budget Impact of Oral Prolonged-Release Fampridine for Management of Walking Disability Associated With Multiple Sclerosis in Taiwan

Value in Health - United Kingdom
doi 10.1016/j.jval.2012.08.431
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pnd139 - Impact of Prolonged-Release Fampridine on Fatigue Among People With Multiple Sclerosis in a Multi-Country Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Prolonged-Release Fampridine Treatment Improved Subject-Reported Impact of Multiple Sclerosis: Item-Level Analysis of the MSIS-29

Journal of the Neurological Sciences
Neurology
2016English

Walking, Quality of Life, and Safety With Prolonged-Release Fampridine Treatment in Clinical Practice: Interim Results of the Liberate Study

Journal of the Neurological Sciences
Neurology
2015English

Budget Impact Analysis of Delayed-Release Dimethylfumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Low Testosterone Is Associated With Disability in Men With Multiple Sclerosis

Multiple Sclerosis
Neurology
2014English

Pnd38 - Economic Impact of Multiple Sclerosis in Patients With Low Physical Disability

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Understanding Walking Activity in Multiple Sclerosis: Step Count, Walking Intensity and Uninterrupted Walking Activity Duration Related to Degree of Disability

Neurological Sciences
DermatologyMedicinePsychiatryNeurologyMental Health
2016English

The Impact of Dynamic Balance Measures on Walking Performance in Multiple Sclerosis

Neurorehabilitation and Neural Repair
NeurologyRehabilitation
2014English

Pnd144 - Reported Quality of Life in People With Multiple Sclerosis Under Long Term Treatment With Fampridine

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy